NEW DELHI: Panacea Biotec along with Russia’s Autonomous wealth Finance, Russian Direct Investment Fund (RDIF) announced the start of Creation of Their Sputnik V vaccine.
The industrial fabrication will be starting in summertime. Beneath a tie-up, RDIF and Panacea have consented to make 100 million doses each year of this vaccine. Efficacy of Sputnik V is 97.6 percent.
